These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines. Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002 [TBL] [Abstract][Full Text] [Related]
4. [Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma: an in vitro experiment study]. Zhang H; Cheng JQ; Huang Q; Yang J; Shen B; Zhou ZK; Kang PD; Lian YY; Pei FX Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2603-8. PubMed ID: 19080706 [TBL] [Abstract][Full Text] [Related]
5. Cotranscription and intergenic splicing of the PPARG and TSEN2 genes in cattle. Roux M; Levéziel H; Amarger V BMC Genomics; 2006 Apr; 7():71. PubMed ID: 16595010 [TBL] [Abstract][Full Text] [Related]
6. Dexamethasone regulation of cFos mRNA in osteoprogenitors. Shur I; Socher R; Benayahu D J Cell Physiol; 2005 Jan; 202(1):240-5. PubMed ID: 15389524 [TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Haydon RC; Luu HH; He TC Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380 [TBL] [Abstract][Full Text] [Related]
8. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507 [TBL] [Abstract][Full Text] [Related]
9. PPAR gamma: ally and foe in bone metabolism. Wahli W Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021 [TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours. Costa-Guda J; Rosen ED; Jensen RT; Chung DC; Arnold A Clin Endocrinol (Oxf); 2005 May; 62(5):603-6. PubMed ID: 15853832 [TBL] [Abstract][Full Text] [Related]
11. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600 [TBL] [Abstract][Full Text] [Related]
12. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation. Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556 [TBL] [Abstract][Full Text] [Related]
13. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Voltan S; Martines D; Elli M; Brun P; Longo S; Porzionato A; Macchi V; D'Incà R; Scarpa M; Palù G; Sturniolo GC; Morelli L; Castagliuolo I Gastroenterology; 2008 Oct; 135(4):1216-27. PubMed ID: 18722375 [TBL] [Abstract][Full Text] [Related]
14. Progesterone is extensively metabolized in osteoblasts: implications for progesterone action on bone. Quinkler M; Kaur K; Hewison M; Stewart PM; Cooper MS Horm Metab Res; 2008 Oct; 40(10):679-84. PubMed ID: 18537080 [TBL] [Abstract][Full Text] [Related]
15. Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization. Seriwatanachai D; Krishnamra N; van Leeuwen JP J Cell Biochem; 2009 Jul; 107(4):677-85. PubMed ID: 19365811 [TBL] [Abstract][Full Text] [Related]
16. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Zieleniak A; Wójcik M; Woźniak LA Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859 [TBL] [Abstract][Full Text] [Related]
17. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. Almeida M; Ambrogini E; Han L; Manolagas SC; Jilka RL J Biol Chem; 2009 Oct; 284(40):27438-48. PubMed ID: 19657144 [TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats. Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner. Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Xiao J; Leung JC; Chan LY; Guo H; Lai KN Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]